Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $1.44 down -4.00% from the previous closing price of $1.50. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 4.78 million shares were traded. ESPR stock price reached its highest trading level at $1.49 during the session, while it also had its lowest trading level at $1.42.
Ratios:
For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’25 when Halladay Benjamin sold 3,535 shares for $1.48 per share. The transaction valued at 5,242 led to the insider holds 481,710 shares of the business.
Warren Eric sold 2,433 shares of ESPR for $3,618 on Mar 18 ’25. The Chief Commercial Officer now owns 370,326 shares after completing the transaction at $1.49 per share. On Mar 18 ’25, another insider, Koenig Sheldon L., who serves as the President and CEO of the company, sold 13,047 shares for $1.50 each. As a result, the insider received 19,623 and left with 1,571,962 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 296773920 and an Enterprise Value of 731353408. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.86. Its current Enterprise Value per Revenue stands at 2.201 whereas that against EBITDA is 13.428.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.84, which has changed by -0.5 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.47. The 50-Day Moving Average of the stock is -18.51%, while the 200-Day Moving Average is calculated to be -31.26%.
Shares Statistics:
Over the past 3-months, ESPR traded about 4.22M shares per day on average, while over the past 10 days, ESPR traded about 3824470 shares per day. A total of 195.85M shares are outstanding, with a floating share count of 194.37M. Insiders hold about 1.76% of the company’s shares, while institutions hold 65.77% stake in the company. Shares short for ESPR as of 1741910400 were 28900005 with a Short Ratio of 6.85, compared to 1739491200 on 28100794. Therefore, it implies a Short% of Shares Outstanding of 28900005 and a Short% of Float of 14.649999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
